Ascelia Pharma AB: ifrs:EquityAndLiabilities
| Value | {"amount": 333493000.0} |
|---|---|
| Period | (as of 2021-12-31) |
| Status | current |
| Entity | Ascelia Pharma AB |
Provenance
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
Retrieved: 2026-08-24T00:48:13.043004+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/abb64bc4-d248-4747-9757-2dc8f1a5d5ba
Source: ESEF — Europäische Jahresabschlüsse (iXBRL) (Public filings (ESEF-Verordnung))
Reference:
esef:5493002YR9VCJJPWYN08:2022-12-31Retrieved: 2026-08-24T00:48:13.043004+02:00
Raw response sha256:
43d1adb5ca312ab8da0fc9e071699a1a…Cite as: FACTANKER, https://factanker.com/fact/abb64bc4-d248-4747-9757-2dc8f1a5d5ba
History
- no predecessors — first report